Ivan Kairatov's extensive experience in research and development within the biopharma industry offers invaluable insights into the innovative approaches transforming precision oncology. Today, he shares his expertise on the recent advancements in treating soft tissue sarcomas (STS),
In an era where medical advancements are accelerating at an unprecedented pace, the collaboration between Danaher Corporation and AstraZeneca represents a pivotal moment for personalized healthcare. These two industry giants have joined forces to develop AI-powered diagnostics that promise to
In today's high-paced healthcare industry, maintaining accurate and timely electronic health records (EHRs) remains a significant challenge, with documentation errors causing widespread disruption. These errors can lead to costly consequences, particularly through denied insurance claims and
In a groundbreaking endeavor to revolutionize cancer treatment, the University of California San Diego has embarked on a six-year initiative funded by a substantial contract awarded by the Advanced Research Projects Agency for Health (ARPA-H). This ambitious project, named "Dynamic Digital
In recent years, the convergence of artificial intelligence (AI) and marine biology has opened new avenues for drug discovery, capturing the attention of the scientific community. At the heart of this novel approach lies the venom of the elusive cone snail—small, venomous marine mollusks found in c
In the rapidly advancing world of laboratory automation, Instromeda Ltd., an innovative small and medium-sized enterprise (SME), is making significant strides with its flagship product, the SPR Neo. At the forefront of automating complex biophysical analyses, the company is preparing to demonstrate
